Michael Ackermann - 05 May 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
05 May 2022
Transactions value $
$1,350,000
Form type
4
Filing time
09 May 2022, 16:42:24 UTC
Previous filing
03 Dec 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Purchase $1.35M +100K $13.50 100K 05 May 2022 By the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 F1, F2
holding TARS Common Stock 1.2M 05 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the shares of common stock reported hereby from the underwriters in an underwritten public offering conducted by the Issuer pursuant to an underwriting agreement, dated May 2, 2022, between the Issuer and the representatives of the several underwriters. Each share of common stock was sold by the underwriters at a price of $13.50 per share.
F2 The Reporting Person is the trustee of the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 and has voting and dispositive power with respect to these shares.